Search results
Prometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?
Zacks via Yahoo Finance· 1 year agoPrometheus Biosciences, Inc. (RXDX) was a big mover last session on higher-than-average trading...
Prometheus Biosciences, Inc. (RXDX) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) delivered earnings and revenue surprises of -1.12% and 26.37%,...
Prometheus Biosciences (NASDAQ:RXDX) pulls back 15% this week, but still delivers shareholders...
Simply Wall St. via Yahoo Finance· 2 years agoIt's been a soft week for Prometheus Biosciences, Inc. (NASDAQ:RXDX) shares, which are down 15%. But...
What Makes Prometheus Biosciences, Inc. (RXDX) a New Buy Stock
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) might move higher on growing optimism about its earnings...
What Makes Prometheus Biosciences (RXDX) an Attractive Investment Choice?
Insider Monkey via Yahoo Finance· 1 year agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter...
Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck
Zacks via Yahoo Finance· 1 year agoPrometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product...
With 67% ownership, Prometheus Biosciences, Inc. (NASDAQ:RXDX) boasts of strong institutional...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Prometheus Biosciences implies that they have...
Prometheus Biosciences, Inc. (RXDX) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Positive Clinical Trial Results Pushed Prometheus Biosciences (RXDX) in Q4
Insider Monkey via Yahoo Finance· 1 year agoAlger Capital, an investment management company, released its “Alger Small Cap Focus Fund” fourth...
Wall Street Analysts Think Prometheus Biosciences, Inc. (RXDX) Could Surge 33.49%: Read This Before...
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for Prometheus Biosciences, Inc. (RXDX) points to a 33.5% upside...